key: cord-0776116-zf3nym0z
authors: Reyes-Capo, Daniela P.; Stevens, Shanlee M.; Cavuoto, Kara M.
title: Acute abducens nerve palsy following COVID-19 vaccination
date: 2021-05-24
journal: J AAPOS
DOI: 10.1016/j.jaapos.2021.05.003
sha: 59a19a92df50e718d79f7d0475e5515524fcb302
doc_id: 776116
cord_uid: zf3nym0z

We report the case of a healthy 59-year-old woman who presented with an acute abducens nerve palsy 2 days after receiving the Pfizer-BioNTech COVID-19 vaccine. In adults, such palsies are typically caused by microvascular disease or compressive tumors, although they have also been described after routine vaccinations. Given the temporal relationship between vaccination and the onset of symptoms, the lack of preexisting medical conditions, and unremarkable magnetic resonance imaging, the patient’s abducens nerve palsy was felt to be related to her vaccination. This case highlights the importance of recognizing the potential of a COVID-19 vaccine to have neurologic sequelae similar to those that as have been reported with the virus itself as well as with other vaccines.

We report the case of a healthy 59-year-old woman who presented with an acute abducens nerve palsy 2 days after receiving the Pfizer-BioNTech COVID-19 vaccine. In adults, such palsies are typically caused by microvascular disease or compressive tumors, although they have also been described after routine vaccinations. Given the temporal relationship between vaccination and the onset of symptoms, the lack of preexisting medical conditions, and unremarkable magnetic resonance imaging, the patient's abducens nerve palsy was felt to be related to her vaccination. This case highlights the importance of recognizing the potential of a COVID-19 vaccine to have neurologic sequelae similar to those that as have been reported with the virus itself as well as with other vaccines.

A previously healthy 59-year-old woman presented emergently to the Bascom Palmer Eye Institute with acute binocular and painless, horizontal diplopia 2 days after receiving the Pfizer-BioNTech COVID-19 vaccine. She reported 1 day of fever; however, the remainder of her review of systems was unremarkable, and there were no other neurologic symptoms, including facial or generalized weakness, gait abnormality, paresthesias, and anosmia. At presentation, her best-corrected visual acuity was 20/25 in each eye. Intraocular pressure in each eye was within normal limits, and there was no afferent pupillary defect. On sensorimotor examination, the patient had a new right esotropia of 25 Δ in primary gaze, 30 Δ in right gaze, and 10 Δ in left gaze as well as a severe abduction deficit of the right eye ( Figure 1 ). Pictures taken before these ocular motor findings developed demonstrated no prior eye misalignment. Slit-lamp and fundus examination were unremarkable. The erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were both mildly elevated, at 42 mm/hr and 0.8 mg/dL, respectively. Magnetic resonance imaging (MRI) of the brain and orbits with and without gadolinium at time of J o u r n a l P r e -p r o o f presentation showed no abnormal signal, enhancement, mass lesion or mass effect. The patient was diagnosed with an abducens nerve palsy with a likely association to the COVID-19 vaccine, given the temporal relationship. Although her fever resolved, her sensorimotor examination remained unchanged at the most recent follow-up.

Abducens nerve palsy is the most frequent isolated ocular motor nerve palsy, with an annual incidence of 11.3/100,000. 1,2 In children, abducens nerve palsies are often associated with trauma, elevated intracranial pressure, neoplasm, or viral infections. 3 In adults, they are more commonly caused by microvascular disease or tumors. 1 Though rare, vaccination-induced ocular motor nerve palsies have also been reported.

Excluding facial nerve palsies, abducens nerve palsies are the most frequent after routine immunization, followed by oculomotor and trochlear nerve palsies. 4 Abducens nerve palsies after immunization were first reported in 1983 by Werner and colleagues, 5 with 2 of 4 children having abducens nerve palsies that following immunizations for diptheria-pertussis-tetanus and rubeolla-mumps-rubella virus. Abducens nerve palsies have also been reported in measlesmumps-rubella, hepatitis B, and annual influenza vaccines, with onset ranging from 2 days to 3 weeks from time of vaccination. [6] [7] [8] Postimmunization abducens nerve palsies typically resolve spontaneously within 6 months, but they can be recurrent. [5] [6] [7] Although the pathophysiology behind postimmunization ocular nerve palsies remains unknown, it is hypothesized to be related to immune-mediated damage resulting in demyelination or localized vasculitis. [4] [5] [6] [7] [8] Isolated case reports of abducens nerve palsies have been described in setting of COVID-19 infection. Falcone and colleagues 9 reported an acute abducens nerve palsy in a healthy 32-year-old man 3 days after developing respiratory symptoms

Isolated abducens nerve palsy: update on evaluation and diagnosis

Incidence, associations, and evaluation of sixth nerve palsy using a population-based method

Sixth nerve palsies in children

Motor palsies of cranial nerves (excluding VII) after vaccination: reports to the US Vaccine Adverse Event Reporting System

Benign recurrent sixth nerve palsies in childhood: secondary to immunization or viral illness

Benign recurrent sixth (abducens) nerve palsy following measles-mumps-rubella vaccination

Recurrent isolated sixth nerve palsy after consecutive annual influenza vaccinations in a child

Isolated abducens nerve palsy following neonatal hepatitis B vaccination

Acute abducens nerve palsy in a patient with the novel coronavirus disease (COVID-19)